Zobrazeno 1 - 10
of 835
pro vyhledávání: '"D'Cruz C"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: moliveira@vhio.net., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Howell SJ; The Christie NHS Foundation Trust, Manchester, UK., Dalenc F; Oncopole Claudius Regaud, Institut Universitaire du Cancer-Toulouse, Toulouse, France., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Medica Scientia Innovation Research (MedSIR), Barcelona, Spain; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Gomez HL; Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas (INEN) and Universidad Ricardo Palma, Lima, Peru., Hu X; Shanghai Cancer Center, Fudan University, Shanghai, China., Toi M; Kyoto University Hospital, Kyoto, Japan., Jhaveri K; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Krivorotko P; Petrov Research Institute of Oncology, St Petersburg, Russia., Loibl S; GBG Forschungs GmbH, Neu-Isenburg and Centre for Haematology and Oncology, Frankfurt, Germany., Morales Murillo S; Institut de Recerca Biomèdica, Barcelona, Spain., Okera M; Icon Cancer Centre, Adelaide, SA, Australia., Nowecki Z; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Park YH; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea., Sohn JH; Yonsei University College of Medicine, Yonsei Cancer Center, Seoul, South Korea., Tokunaga E; NHO Kyushu Cancer Center, Fukuoka, Japan., Yousef S; Emek Medical Center, Afula, Israel., Zhukova L; Loginov Moscow Clinical Scientific Center, Moscow, Russia., Fulford M; Oncology R&D, AstraZeneca, Warsaw, Poland., Andrews H; Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Wadsworth I; Oncology R&D, AstraZeneca, Cambridge, UK; PHASTAR, London, UK., D'Cruz C; Oncology R&D, AstraZeneca, Waltham, MA, USA., Turner NC; Royal Marsden Hospital, Institute of Cancer Research, London, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. 1231-1244.
Autor:
Schmid, P., McArthur, H.L., Cortés, J., Xu, B., Cardoso, F., Casalnuovo, M.L., Demirci, U., Freitas, R., Jr, Ghosh, J., Hegg, R., Iwata, H., Lopez Chuken, Y.A., Nechaeva, M., Robson, M.E., Villalobos Valencia, R., Lloyd, A., D'Cruz, C., Foxley, A., Park, Y.H.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S1212-S1213
Autor:
Jones RDO; Oncology R&D, Research and Early Development, AstraZeneca, Cambridge, UK., Grondine M; Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., Borodovsky A; Formerly Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., San Martin M; Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., DuPont M; Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., D'Cruz C; Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., Schuller A; Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., Henry R; Formerly Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., Barry E; Formerly Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., Castriotta L; Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., Anjum R; Oncology R&D, Research and Early Development, AstraZeneca, Boston, Massachusetts, USA., Petersson K; qPharmetra LLC, Stockholm, Sweden., Sahota T; BioPharmaceuticals R&D, Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, UK., Ahmed GF; Formerly BioPharmaceuticals R&D, Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, UK.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2021 Feb; Vol. 178 (3), pp. 600-613. Date of Electronic Publication: 2020 Dec 07.
Autor:
Lobo J; School of Sustainability, College of Global Futures, Arizona State University, Tempe, Arizona USA., Aggarwal RM; School of Sustainability, College of Global Futures, Arizona State University, Tempe, Arizona USA., Alberti M; Urban Ecology Research Laboratory, Department of Urban Design and Planning, University of Washington, Seattle, Washington USA., Allen-Dumas M; Climate Change Science Institute, Oak Ridge National Laboratory, Oak Ridge, Tennessee USA., Bettencourt LMA; Mansueto Institute for Urban Innovation, University of Chicago, Chicago, Illinois USA., Boone C; School of Sustainability, College of Global Futures, Arizona State University, Tempe, Arizona USA., Brelsford C; Human Dynamics Section, Oak Ridge National Laboratory, Oak Ridge, Tennessee USA., Broto VC; Urban Institute, University of Sheffield, Sheffield, United Kingdom., Eakin H; School of Sustainability, College of Global Futures, Arizona State University, Tempe, Arizona USA., Bagchi-Sen S; School of Geographical Sciences and Urban Planning, Arizona State University, Tempe, Arizona USA., Meerow S; School of Geographical Sciences and Urban Planning, Arizona State University, Tempe, Arizona USA., D'Cruz C; International Centre for Climate Change and Development, Dhaka, Bangladesh., Revi A; Indian Institute for Human Settlements, Bangalore, India., Roberts DC; School of Life Sciences, University of KwaZulu-Natal; Sustainable and Resilient City Initiatives Unit, EThekwini Municipality, Durban, Republic of South Africa., Smith ME; School of Human Evolution and Social Change, Arizona State University, Tempe, Arizona USA., York A; School of Human Evolution and Social Change, Arizona State University, Tempe, Arizona USA., Lin T; Institute of Urban Environment, Chinese Academy of Sciences, Xiamen, People's Republic of China., Bai X; Fenner School of Environment & Society, Australian National University, Canberra, Australia., Solecki W; Institute for Sustainable Cities, Hunter College, City University of New York, New York, New York, USA., Pataki D; School of Sustainability, College of Global Futures, Arizona State University, Tempe, Arizona USA., Tapia LB; Laboratorio Nacional de Ciencias de la Sostenibilidad, Instituto de Ecología, National Autonomous University of Mexico, Mexico D.F., Mexico., Rockman M; Department of Anthropology, University of Maryland, College Park, Maryland USA., Wolfram M; Leibniz Institute of Ecological Urban and Regional Development, Dresden, Federal Republic of Germany., Schlosser P; Julie Ann Wrigley Global Futures Laboratory, Arizona State University, Tempe, Arizona USA., Gauthier N; Florida Museum of Natural History, University of Florida, Gainesville, Florida USA.
Publikováno v:
Npj urban sustainability [NPJ Urban Sustain] 2023; Vol. 3 (1), pp. 32. Date of Electronic Publication: 2023 Jun 10.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Applied Physics; 10/1/1985, Vol. 58 Issue 7, p2724, 7p, 4 Black and White Photographs, 2 Diagrams, 2 Graphs
Publikováno v:
Journal of Clinical & Experimental Pathology.
Pure primary Signet-Ring Cell Carcinoma (SRCC) of lung is an extremely rare entity. Typically seen in nonsmokers, it is considered to be highly invasive, highly aggressive and carries a worse prognosis when compared to other types of lung tumors. Cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7ca8911aeac50e5ee9793c7c41fd261
https://doi.org/10.4172/2161-0681.1000155
https://doi.org/10.4172/2161-0681.1000155
Publikováno v:
In Annals of Oncology October 2018 29 Supplement 8